The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia. 2016

Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
Department of Physiology, McIntyre Medical Sciences Building, McGill University, Montreal, Canada; McGill CF Translational Research Centre, Montreal, Canada; mark.turner2@mail.mcgill.ca.

Cystic fibrosis (CF), a genetic disease caused by mutations in the CFTR gene, is a life-limiting disease characterized by chronic bacterial airway infection and severe inflammation. Some CFTR mutants have reduced responsiveness to cAMP/PKA signaling; hence, pharmacological agents that elevate intracellular cAMP are potentially useful for the treatment of CF. By inhibiting cAMP breakdown, phosphodiesterase (PDE) inhibitors stimulate CFTR in vitro and in vivo. Here, we demonstrate that PDE inhibition by RPL554, a drug that has been shown to cause bronchodilation in asthma and chronic obstructive pulmonary disease (COPD) patients, stimulates CFTR-dependent ion secretion across bronchial epithelial cells isolated from patients carrying the R117H/F508del CF genotype. RPL554-induced CFTR activity was further increased by the potentiator VX-770, suggesting an additional benefit by the drug combination. RPL554 also increased cilia beat frequency in primary human bronchial epithelial cells. The results indicate RPL554 may increase mucociliary clearance through stimulation of CFTR and increasing ciliary beat frequency and thus could provide a novel therapeutic option for CF.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D009079 Mucociliary Clearance A non-specific host defense mechanism that removes MUCUS and other material from the LUNGS by ciliary and secretory activity of the tracheobronchial submucosal glands. It is measured in vivo as mucus transfer, ciliary beat frequency, and clearance of radioactive tracers. Mucociliary Transport,Clearance, Mucociliary,Clearances, Mucociliary,Mucociliary Clearances,Mucociliary Transports,Transport, Mucociliary,Transports, Mucociliary
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D017136 Ion Transport The movement of ions across energy-transducing cell membranes. Transport can be active, passive or facilitated. Ions may travel by themselves (uniport), or as a group of two or more ions in the same (symport) or opposite (antiport) directions. Antiport,Ion Cotransport,Ion Exchange, Intracellular,Symport,Uniport,Active Ion Transport,Facilitated Ion Transport,Passive Ion Transport,Cotransport, Ion,Exchange, Intracellular Ion,Intracellular Ion Exchange,Ion Transport, Active,Ion Transport, Facilitated,Ion Transport, Passive,Transport, Active Ion,Transport, Ion
D058987 Phosphodiesterase 3 Inhibitors Compounds that specifically inhibit PHOSPHODIESTERASE 3. PDE3 Inhibitor,Phosphodiesterase 3 Inhibitor,Phosphodiesterase Type 3 Inhibitor,PDE-3 Inhibitors,PDE3 Inhibitors,Phosphodiesterase Type 3 Inhibitors,3 Inhibitor, Phosphodiesterase,Inhibitor, PDE3,Inhibitor, Phosphodiesterase 3,Inhibitors, PDE-3,Inhibitors, PDE3,Inhibitors, Phosphodiesterase 3,PDE 3 Inhibitors
D058988 Phosphodiesterase 4 Inhibitors Compounds that specifically inhibit PHOSPHODIESTERASE 4. PDE-4 Inhibitor,PDE4 Inhibitor,Phosphodiesterase 4 Inhibitor,Phosphodiesterase Type 4 Inhibitor,PDE-4 Inhibitors,PDE4 Inhibitors,Phosphodiesterase Type 4 Inhibitors,4 Inhibitor, Phosphodiesterase,Inhibitor, PDE-4,Inhibitor, PDE4,Inhibitor, Phosphodiesterase 4,Inhibitors, PDE-4,Inhibitors, PDE4,Inhibitors, Phosphodiesterase 4,PDE 4 Inhibitor,PDE 4 Inhibitors

Related Publications

Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
May 2020, American journal of physiology. Lung cellular and molecular physiology,
Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
November 2018, The European respiratory journal,
Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
September 2013, The Journal of pharmacology and experimental therapeutics,
Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
June 2015, Pulmonary pharmacology & therapeutics,
Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
September 2003, The American journal of pathology,
Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
December 2002, Experimental biology and medicine (Maywood, N.J.),
Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
December 2021, American journal of physiology. Lung cellular and molecular physiology,
Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
February 2020, Respiratory research,
Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
March 2023, Cells,
Mark J Turner, and Elizabeth Matthes, and Arnaud Billet, and Amy J Ferguson, and David Y Thomas, and Scott H Randell, and Lawrence E Ostrowski, and Kathy Abbott-Banner, and John W Hanrahan
November 2018, Pharmaceutical patent analyst,
Copied contents to your clipboard!